Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?

Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, Davis BR, Alderman MH, Gordon D, Furberg CD, Franklin SS, Blumenthal SS, Castaldo RS, Preston RA; LHAT Collaborative Research Group.

Stat Med. 2013 Feb 28;32(5):884-97. doi: 10.1002/sim.5580. Epub 2012 Sep 7.

PMID:
22961832
[PubMed - indexed for MEDLINE]
2.

Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.

Lynch AI, Eckfeldt JH, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Arnett DK.

Pharmacogenet Genomics. 2012 May;22(5):355-66. doi: 10.1097/FPC.0b013e3283516ff8.

PMID:
22388798
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Thiazide and loop diuretics.

Sica DA, Carter B, Cushman W, Hamm L.

J Clin Hypertens (Greenwich). 2011 Sep;13(9):639-43. doi: 10.1111/j.1751-7176.2011.00512.x. Epub 2011 Jul 27. Review.

PMID:
21896142
[PubMed - indexed for MEDLINE]
4.

Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?

Grimm RH, Davis BR, Piller LB, Cutler JA, Margolis KL, Barzilay J, Dart RA, Graumlich JF, Murden RA, Randall OS; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2009 Sep;11(9):466-74. doi: 10.1111/j.1751-7176.2009.00149.x.

PMID:
19751458
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH; ALLHAT Collaborative Research Group.

Arch Intern Med. 2009 May 11;169(9):832-42. doi: 10.1001/archinternmed.2009.60.

PMID:
19433694
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17. doi: 10.1001/archinternmed.2007.66.

PMID:
18227370
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.

Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK.

JAMA. 2008 Jan 23;299(3):296-307. doi: 10.1001/jama.299.3.296. Erratum in: JAMA. 2009 Sep 9;302(10):1057-8.

PMID:
18212314
[PubMed - indexed for MEDLINE]
8.

Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Margolis KL, Piller LB, Ford CE, Henriquez MA, Cushman WC, Einhorn PT, Colon PJ Sr, Vidt DG, Christian R, Wong ND, Wright JT Jr, Goff DC Jr; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2007 Nov;50(5):854-61. Epub 2007 Sep 10.

PMID:
17846352
[PubMed - indexed for MEDLINE]
Free Article
9.

The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR; ALLHAT Collaborative Research Group.

Am Heart J. 2007 Jan;153(1):42-53.

PMID:
17174636
[PubMed - indexed for MEDLINE]
10.

Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, Retta TM, Probstfield JL; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2006 Sep;8(9):649-56; quiz 657-8.

PMID:
16957427
[PubMed - indexed for MEDLINE]
11.

Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.

Davis BR, Arnett DK, Boerwinkle E, Ford CE, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH.

Pharmacogenomics J. 2007 Apr;7(2):112-22. Epub 2006 May 16.

PMID:
16702981
[PubMed - indexed for MEDLINE]
12.

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.

PMID:
16651474
[PubMed - indexed for MEDLINE]
Free Article
13.

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.

Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH.

Circulation. 2005 Jun 28;111(25):3374-83. Epub 2005 Jun 20.

PMID:
15967849
[PubMed - indexed for MEDLINE]
Free Article
14.

[ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].

Kuwajima I.

Nihon Rinsho. 2004 Mar;62 Suppl 3:648-53. Review. Japanese. No abstract available.

PMID:
15171450
[PubMed - indexed for MEDLINE]
15.

Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Papademetriou V, Piller LB, Ford CE, Gordon D, Hartney TJ, Geraci TS, Reisin E, Sumner BM, Wong ND, Nwachuku C, Narayan P, Haywood J, Habib G; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2003 Nov-Dec;5(6):377-84.

PMID:
14688492
[PubMed - indexed for MEDLINE]
16.

[The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].

Düsing R.

MMW Fortschr Med. 2003;145 Suppl 1:6. German. No abstract available.

PMID:
12958795
[PubMed - indexed for MEDLINE]
17.

ALLHAT. Is it all hat?

Glancy DL.

J La State Med Soc. 2003 Mar-Apr;155(2):68-70. No abstract available.

PMID:
12778985
[PubMed - indexed for MEDLINE]
18.

[ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].

Slany J.

Wien Klin Wochenschr. 2003 Mar 31;115(5-6):149-51. German. No abstract available.

PMID:
12741071
[PubMed - indexed for MEDLINE]
19.

[Treating hypertension is more important than the choice of agent; results from the largest clinical trial until now].

de Leeuw PW, Birkenhäger WH.

Ned Tijdschr Geneeskd. 2003 Apr 12;147(15):685-9. Dutch.

PMID:
12722529
[PubMed - indexed for MEDLINE]
20.

Diuretics: older, cheaper, better.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2003 Apr;15(2):1-2. No abstract available.

PMID:
12712964
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk